Clinical Practice

Support Is Not Treatment: Vets Need a Shared Supplement Language

A DVM 360 commentary argues that "support" and "treatment" are not interchangeable, and that clearer supplement vocabulary protects both pets and expectations.

Updated

DVM 360 has published a commentary under a blunt headline — "Support is not treatment" — that pushes veterinarians and pet owners toward a shared vocabulary when they discuss supplements.

The piece, carried on the DVM 360 news feed, centers on a distinction the profession uses inconsistently: a product that supports a body system is not the same as a product that treats a diagnosed disease. That gap in language, the author argues, fuels mismatched expectations at the exam table.

Why does the wording matter?

When a veterinarian recommends a joint, coat, or cognitive supplement, the owner often hears a therapeutic claim. The commentary's core point is lexical and practical at once: "support" describes maintenance or adjunctive use, while "treatment" implies an approved intervention against a diagnosed condition.

Without that shared language, the author contends, two failure modes follow. Owners may expect drug-level results from products formulated and regulated as supplements. Or they may forgo evidence-based therapy because a support product carries an implied medical promise.

What changes at the exam table?

The DVM 360 piece frames the fix as a conversation habit rather than a protocol change. Veterinarians who state plainly what a supplement does — and does not do — before recommending it can align expectations with the product's actual role.

That framing matters commercially as well as clinically. Supplements occupy a large share of the consumer pet-care market, and the commentary's title itself — "Support is not treatment: A shared language for the supplement conversation" — signals a push to keep those purchases anchored to honest clinical categories.

What the piece does not claim

The commentary does not evaluate specific products, brands, or ingredients, and it does not cite clinical trial data. It is an argument about vocabulary and communication, not a study. Readers seeking efficacy evidence for individual supplements will need to look elsewhere.

Regulatory status also stays outside the article's scope. In the United States, animal health products occupy different oversight tracks depending on their claims — a distinction the piece gestures toward with its title but does not detail by agency.

As supplement spending grows, expect the profession's language around these products — support versus treatment — to receive more formal attention in veterinary communication guidance.

Source: Google News: Veterinary medicine

Share this article:

Grace Kim

Show full bio

Staff writer covering regulation, policy and their impact on Small- and large-animal clinical practice at The Vet Scope.

More from Grace Kim →